DocSym
β
Searchsearch
Search
(D46.9) Myelodysplastic syndrome, unspecified
More details coming soon
2 030 090 in individuals diagnosis myelodysplastic syndrome, unspecified confirmed
215 512 deaths with diagnosis myelodysplastic syndrome, unspecified
11% mortality rate associated with the disease myelodysplastic syndrome, unspecified
Diagnosis myelodysplastic syndrome, unspecified is diagnosed Men are 4.72% more likely than Women
1 062 928
Men receive the diagnosis myelodysplastic syndrome, unspecified
122 283 (11.5 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
967 162
Women receive the diagnosis myelodysplastic syndrome, unspecified
93 229 (9.6 %)Died from this diagnosis.
Risk Group for the Disease myelodysplastic syndrome, unspecified - Men and Women aged 75-79
In Men diagnosis is most often set at age 0-95+
in in men, the disease manifests at any agein in women, the disease manifests at any age
In Women diagnosis is most often set at age 0-95+
Disease Features myelodysplastic syndrome, unspecified
Absence or low individual and public risk
Myelodysplastic syndrome, unspecified - what does this mean
Myelodysplastic syndrome (mds) is a group of disorders caused by the abnormal production of blood cells in the bone marrow. it results from acquired genetic changes in the bone marrow cells that disrupt normal bone marrow function and the production of healthy blood cells. in mds, the bone marrow produces too few healthy blood cells, which can lead to anemia, infection, and bleeding.
What happens during the disease - myelodysplastic syndrome, unspecified
Myelodysplastic syndrome is a group of disorders caused by a defect in the production of healthy blood cells. this defect is caused by a combination of genetic and environmental factors, which can include exposure to certain chemicals, radiation, or certain medications. the defect can cause the bone marrow to produce an insufficient amount of healthy blood cells, leading to anemia, infections, and an increased risk of developing certain types of cancer.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Complete blood count (CBC)
- Peripheral blood smear
- Bone marrow examination
- Cytogenetic analysis
- Flow cytometry
- Immunophenotyping
- Molecular testing
- Serum iron studies
- Serum vitamin B12 and folate levels
Treatment and Medical Assistance
Main Goal: To reduce the risk of progression to acute myeloid leukemia and to improve the patient's quality of life.
- Administering medications such as growth factors, immunosuppressants, and chemotherapy.
- Performing stem cell transplants.
- Undergoing radiation therapy.
- Monitoring blood cell counts and other laboratory tests.
- Managing symptoms such as fatigue, anemia, and infections.
- Evaluating for and treating any underlying infections or other medical conditions.
- Providing supportive care such as pain management.
- Providing psychological and emotional support.
12 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Myelodysplastic syndrome, unspecified - Prevention
The best way to prevent myelodysplastic syndrome (mds) is to maintain a healthy lifestyle. this includes eating a balanced diet, exercising regularly, avoiding smoking and drinking alcohol, and getting regular check-ups with your doctor. additionally, it is important to take any medications prescribed by your doctor and to follow their instructions carefully.